RPS welcomes Welsh Government investment in clinical skills training
The Royal Pharmaceutical Society in Wales has welcomed the continued commitment of the Welsh Government to community pharmacy and the announcement of an additional investment of£100,000 in phar (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 23, 2019 Category: Drugs & Pharmacology Source Type: news

Supply issues ethinylestradiol 30 microgram/levonorgestrel 150microgram and diamorphine 5mg injection
Information from the Department of Health and Social Care (DHSC) regarding the following supply issues: Bayer hasnotified the DHSC that due to capacity constraints, Microgynon 30 tablets will be out (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 23, 2019 Category: Drugs & Pharmacology Source Type: news

Pharmacy apprenticeships on hold
The Institute for Apprenticeships and Technical Education has announced that proposals for a five-year pharmacy apprenticeship are on hold until representatives from a wider range of pharmacy sectors (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 23, 2019 Category: Drugs & Pharmacology Source Type: news

Join us at Pride 2019
We’re excited to announce we have places in the walking parade at this year’s Pride, the UK’s biggest celebration of everything LGBT+. The route winds through the heart of London&rs (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 22, 2019 Category: Drugs & Pharmacology Source Type: news

Results from the RPS National Pharmacy Board elections 2019
We are pleased to announce the results from this year’s RPS National Pharmacy Board elections. English Pharmacy Board Election The following candidates have been elected to the five substantiv (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 17, 2019 Category: Drugs & Pharmacology Source Type: news

DNP (2,4 dinitrophenol) toxicity
Public health England (PHE’s) has issued an alert to provide advice on DNP (2,4 dinitrophenol) toxicity... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 17, 2019 Category: Drugs & Pharmacology Source Type: news

Karen Baxter appointed Managing Director of Pharmaceutical Press
Karen Baxter MRPharmS has been appointed as Managing Director of Pharmaceutical Press (PhP). Her appointment starts with immediate effect after an eight-month period as Interim MD. Karenwas previousl (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 14, 2019 Category: Drugs & Pharmacology Source Type: news

Prescription charges system needs overhaul says RPS in England
Responding to the National Audit Office’s Investigation into penalty charge notices in healthcare,Chair of the Royal Pharmaceutical Society in England Sandra Gidley said:“The National Au (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 14, 2019 Category: Drugs & Pharmacology Source Type: news

Class 2 Medicines Recall: Co-amoxiclav 125 mg/31.25 mg/5 ml and 25 mg/62.5 mg/5 ml powder for oral suspension
The MHRA has issued a recall for two batches of Co-amoxiclav 125 mg/31.25 mg/5 ml and 25 mg/62.5 mg/5 ml powder for oral suspension from pharmacies. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 13, 2019 Category: Drugs & Pharmacology Source Type: news

RPS in Scotland calls on Scottish Government to fund pharmaceutical care in care homes
The Royal Pharmaceutical Society in Scotlandhas today welcomed NHS England’s recognition of the vital role pharmacists can play in care homes. Alex MacKinnon, Director of RPS in Scotland said: (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 10, 2019 Category: Drugs & Pharmacology Source Type: news

Elen Jones appointed Director of RPS in Wales
Elen Jones has been appointed as the new RPS Director for Wales. This important role is accountable for national policy development, professional advocacy and member engagement across Wales, in partne (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 10, 2019 Category: Drugs & Pharmacology Source Type: news

RPS welcomes plan for more pharmacists in care homes
NHS England today announced that it is recruiting a total of 200 new pharmacists and pharmacy technicians into care homes, with many already in place. Working with the care home team, theyhelp reduce (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 10, 2019 Category: Drugs & Pharmacology Source Type: news

Company led drug alert - Macopharma intravenous infusion bags
Macopharma is recalling certain batches of intravenous infusion bags as a precaution... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 8, 2019 Category: Drugs & Pharmacology Source Type: news

Use of antiviral medicines in primary care (England) – prescribers and community pharmacists
Antiviral medicines may no longer be prescribed and dispensed in primary care for the prevention and treatment of influenza at NHS expense. This does not impact on prescribing of antiviral medicines (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 8, 2019 Category: Drugs & Pharmacology Source Type: news

RPS tells Institute of Apprenticeships about members' concerns
The RPS attended a stakeholder meeting at the invitation of the IFA on 02 May regarding proposals around degree apprenticeships to inform the IFA of our members immediate concerns, and to hear more ab (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 7, 2019 Category: Drugs & Pharmacology Source Type: news

Epanutin 50mg Infatabs supply issue
Informationfrom the Department of Health and Social Care (DHSC) regarding the Epanutin 50mg Infatabs supply issue... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 3, 2019 Category: Drugs & Pharmacology Source Type: news

Voting now open for the RPS National Board elections 2019
Voting is now open for the RPS National Board elections 2019. This is an opportunity for you to shape the future of your profession in your country. How do I vote? You can cast your vote by visitin (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 29, 2019 Category: Drugs & Pharmacology Source Type: news

RPS secures commitment to publish more information on ‘pharmacy degree apprenticeships’
The Royal Pharmaceutical Society has met with the Institute for Apprenticeships and Technical Education (IFATE) following concerns and questions from RPS members about the recent proposals on degree a (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 26, 2019 Category: Drugs & Pharmacology Source Type: news

Class 4 medicines defect information: prednisolone 5mg tablets
Genus Pharmaceuticals Ltd has informed the MHRA that there is an error on the Braille for certain batches of prednisolone 5mg tablets (PL 42967/0037), where the strength reads as 1mg instead of 5mg. T (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 26, 2019 Category: Drugs & Pharmacology Source Type: news

Class 4 Medicines Defect Information: Ativan 4mg/1ml Solution for injection
Pfizer Limited has informed the MHRA that the text on the carton label for the above product has recently been updated and at this time... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 24, 2019 Category: Drugs & Pharmacology Source Type: news

Pharmacists are “vaccine heroes" too, says RPS England
RPS in England has written to Duncan Selbie, Chief Executive of Public Health England, to highlight the key role of pharmacists in immunisation campaigns, following comments about"vaccine heroes (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 24, 2019 Category: Drugs & Pharmacology Source Type: news

More needs to be done to improve health care for the elderly in care homes
The Royal Pharmaceutical Society (RPS) has published a new report setting out a vision for improving the care of residents in care homes across Scotland. There are over 32 000 elderly care home reside (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 24, 2019 Category: Drugs & Pharmacology Source Type: news

Drug Safety Update: valproate medicines and serious harms in pregnancy - new annual risk acknowledgement form and clinical guidance from professional bodies to support compliance with the Pregnancy Prevention Programme
The Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update advises that ongoing patient survey data suggest that more effort is needed by clinicians to achieve full and timely c (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 18, 2019 Category: Drugs & Pharmacology Source Type: news

RPS England Board meeting – April update
RPS England Board Chair Sandra Gidley comments on key outcomes The English Pharmacy Board gathered as part of their quarterly meetings to be updated on the RPS workplan for this year. They talked a (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 17, 2019 Category: Drugs & Pharmacology Source Type: news

Welsh Government drive to boost pharmacy workforce
RPS in Wales welcomes the Welsh Government's commitment to invest further in the training of pharmacists for the future of healthcare in Wales. Increasing the number of training places and transfo (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 17, 2019 Category: Drugs & Pharmacology Source Type: news

We are asking the Institute for Apprenticeships and Technical Education for urgent clarity
Following on a 10 day consultation on plans to introduce five-year apprenticeship, we are asking the IATE for urgent clarityand greater transparency. In light of the significant reservations expres (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 16, 2019 Category: Drugs & Pharmacology Source Type: news

Updated guidance for pharmacies providing pharmacy services at a distance
The General Pharmaceutical Council (GPhC) has published updated guidance for pharmacies providing pharmacy services at a distance today. The new guidance is aimed at pharmacy owners to help make sure (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 16, 2019 Category: Drugs & Pharmacology Source Type: news

Pharmacy degree apprenticeships
What is the RPS involvement in degree apprenticeships to date? We have not contributed to the pharmacy degree apprenticeship trailblazer up to now. We were notified by the trailblazer group that th (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 12, 2019 Category: Drugs & Pharmacology Source Type: news

Information from the Department of Health and Social Care (DHSC) on supply issue with labetalol tablets, all strengths
DHSC has been made aware of a supply issue with ... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 12, 2019 Category: Drugs & Pharmacology Source Type: news

Levomepromazine 25mg/ml injection supply issue (urgent) – information for primary care from the Department of Health & Social Care (DHSC)
Overview of Supply• Sanofi informed NHS England and DHSC on 5th April 2019 that they are going out of stock this week of levomepromazine 25mg/ml injection and new stock is expected to be availa (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 11, 2019 Category: Drugs & Pharmacology Source Type: news

Class 4 Medicines Defect Information: chloramphenicol 0.5% W/V antibiotic eye drops
Martindale Pharmaceuticals has informed the MHRA of two issues with all unexpired batches of chloramphenicol 0.5% W/V antibiotic eye drops (PL 00156/0109), legal status‘P’. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 9, 2019 Category: Drugs & Pharmacology Source Type: news

Company-led recall: Nutriflex Omega Special 2500ml
B. Braun Medical Ltd is recalling specific batches of Nutriflex Omega Special 2500ml PL 03551/0118 as ongoing stability studies have identified that they may have an out of specification result in the (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 9, 2019 Category: Drugs & Pharmacology Source Type: news

Candidates announced for the RPS National Board Elections 2019
We are delighted to announce we have had a total of 21nominations for this year’s RPS National Pharmacy Board elections. For the English Pharmacy Board election, we have received 11nominations. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 8, 2019 Category: Drugs & Pharmacology Source Type: news

We welcome new Pharmacy Minister
The Department of Health and Social Carehas confirmed the appointment of Seema Kennedy as the new Parliamentary Under Secretary of State for Public Health and Primary Care, with responsibility for pha (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 5, 2019 Category: Drugs & Pharmacology Source Type: news

Our Museum wins Arts Council Accreditation!
We're thrilled to announce that the RPS Museum has retained Full Accreditation from Arts Council England in our latest review. The scheme is the professional standard for museums and galleries in (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 5, 2019 Category: Drugs & Pharmacology Source Type: news

Class 4 medicine defect information: zoledronic acid 5mg solution for infusion
Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed the MHRA that some packs from a batch of zoledronic acid 5mg solution for infusion contain a patient information leaflet for temozolomide 18 (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 4, 2019 Category: Drugs & Pharmacology Source Type: news

Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
New guidance on contraceptive methods and frequency of pregnancy testing to reduce inadvertent exposures during pregnancy.... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 3, 2019 Category: Drugs & Pharmacology Source Type: news

Ambitious vision for pharmacy education will fail without funding
We’ve published our response link to the General Pharmaceutical Council’s consultation on initial education and training standards for pharmacists. The consultation makes a number of prop (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 3, 2019 Category: Drugs & Pharmacology Source Type: news

RPS Welcomes Welsh Government investment in Community Pharmacy
A recent announcement by the Welsh Government to make an increase in community pharmacy funding of£1.4m in 2018-19 has been warmly welcomed by the Royal Pharmaceutical Society. Responding to t (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - April 2, 2019 Category: Drugs & Pharmacology Source Type: news

Ravi Sharma appointed to new NHS Assembly
RPS Director for England Ravi Sharma has been appointed to the new NHS Assembly. The Assembly is a national forum of stakeholders from across the health and care system to support the boards of NHS E (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 28, 2019 Category: Drugs & Pharmacology Source Type: news

Ban DNP, RPS advises Home Secretary
RPS President Ash Soni and Chief Pharmacist Gino Martini have written to the Home Secretary, Sajid Javid MP, requesting a ban on deadly diet drug 2,4-Dinitrophenol. DNP is an industrial chemical unfi (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 28, 2019 Category: Drugs & Pharmacology Source Type: news

First ever state-backed indemnity scheme to cover pharmacists
The RPS in England has welcomed new NHS arrangements to introduce a state-backed indemnity scheme for general practice from 1 April 2019. The Clinical Negligence Scheme for General Practice will for t (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 27, 2019 Category: Drugs & Pharmacology Source Type: news

Building up the pharmacy workforce
Commenting on'Closing the Gap', the report on the needs of the NHS workforce in Englandfrom the Nuffield Trust, The King's Fund and the Health Foundation, Sandra Gidley, Chair of the RPS (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 22, 2019 Category: Drugs & Pharmacology Source Type: news

Class 2 Medicines recall: Accord Healthcare Limited — Losartan potassium 50mg and 100mg film-coated tablets
Accord Healthcare Limited is recalling some batches of losartan potassium 50mg and 100mg film-coated tablets. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 22, 2019 Category: Drugs & Pharmacology Source Type: news

MHRA Drug Safety Update - Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects
The MHRA has released a Drug Safety Update regarding new restrictions and precautions for fluoroquinolone antibiotics... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 22, 2019 Category: Drugs & Pharmacology Source Type: news

Calls for greater pharmacist role in prescription drug dependency
RPS Wales haswelcomed areportcalling for NHS Wales to make better use of the expertise of pharmacists in cases ofprescriptiondrug dependence and withdrawal. The report is theresult of evidence gath (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 21, 2019 Category: Drugs & Pharmacology Source Type: news

Company-led recall: Ozurdex 700 micrograms intravitreal implant in applicator (dexamethasone)
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led recall for further batches of Ozurdex 700 micrograms intravitreal implant in applicator (dexamethasone) due to t (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 19, 2019 Category: Drugs & Pharmacology Source Type: news

Rescheduling of gabapentin and pregabalin to Schedule 3 Controlled Drugs from 1 April 2019
Gabapentin and pregabalin will be reclassified to Schedule 3 Controlled Drugs (CDs). This means from 1 April 2019: Prescriptions for gabapentin and pregabalin need to meet full prescription require (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 12, 2019 Category: Drugs & Pharmacology Source Type: news

Interim community pharmacy funding announced
An interim funding agreement has been agreed in advance of the start of actual negotiations on future pharmacy funding. The Department of Health and Social Care and PSNC have agreed community pharmac (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 11, 2019 Category: Drugs & Pharmacology Source Type: news

enFlow IV fluid and blood warmer - risk of unsafe levels of aluminium leaching from device (MDA/2019/015)
The MHRA has released a Medical Device Alert (MDA) for the enFlow IV fluid and blood warmer (manufactured by Vyaire)... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 8, 2019 Category: Drugs & Pharmacology Source Type: news